Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 548ba (MIR548BA)
- Target
- MIR548BA
- Molecular classification
- microRNA (miRNA), Non-coding RNA
01
Overview
MicroRNA 548ba (MIR548BA) is a short, 20–24 nucleotide, non-coding RNA molecule belonging to the microRNA family. It is involved in post-transcriptional regulation of gene expression by binding to complementary sequences on target messenger RNAs (mRNAs), resulting in either translational repression or target degradation[1]. MIR548BA is intronic, transcribed from within the follicle stimulating hormone receptor (FSHR) gene, and plays a regulatory role in granulosa cells. Experimentally validated targets of MIR548BA include genes such as LIFR (leukemia inhibitory factor receptor), PTEN (phosphatase and tensin homolog), NEO1 (neogenin 1), and SP110, all of which are involved in cell signaling pathways relevant to ovarian follicle development, cell growth, and apoptosis[2]. While MIR548BA is implicated in ovarian biology, no direct clinical or therapeutic applications are currently established[2].
- Other names
- hsa-mir-548baMIR548BAmicroRNA mir-548bahsa-miR-548ba
02
Mechanism of action
Not applicable to microRNA 548ba as no drugs specifically target it. In general, microRNAs act by base-pairing with target mRNAs, leading to mRNA destabilization or translational inhibition
03
Biological functions
Post-transcriptional regulation of gene expressionModulation of mRNA stabilitySuppression of mRNA translationRegulation of cell proliferation and apoptosis (through validated targets such as PTEN and BCL2L11)
04
Disease associations
Potential roles in ovarian follicle developmentRegulation of signaling pathways (such as PI3K-Akt), which are involved in cancer and other diseases, but no direct evidence of clinical disease association for this specific miRNA to date
05
Safety considerations
General challenges for microRNA-based therapeutics include off-target effects and delivery issuesNo published safety concerns specific to microRNA 548ba
Beyond the preview
Go deeper on MicroRNA 548ba (MIR548BA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 548ba (MIR548BA).